Intimation of entering into binding agreement for transfer of shares of Curateq Biologics s.r.o. by Helix Healthcare B.V to Curateq Biologics B.V. wholly owned subsidiaries of the Company
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Acquisition
July 30, 2025
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month